| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 3,000 | ₹0.5 66.66% | 2,0000% |
| - | - | 3,100 | ₹1.2 -4% | 9,0000% |
| 2500% | ₹470 0% | 3,200 | ₹2 14.28% | 11,000-8.33% |
| 00% | ₹308 0% | 3,250 | ₹2.3 4.54% | 8,5000% |
| 7500% | ₹245.85 0% | 3,300 | ₹3.6 10.76% | 29,50029.67% |
| 1,0000% | ₹253 0% | 3,350 | ₹6.05 23.46% | 12,750-3.77% |
| 1,5000% | ₹153.6 0% | 3,400 | ₹9.9 10.61% | 86,2504.86% |
| 1,0000% | ₹112.3 0% | 3,450 | ₹18.5 26.71% | 11,2500% |
| 15,00020% | ₹69 -12.43% | 3,500 | ₹31.2 6.84% | 57,7504.05% |
| 30,75023% | ₹42.85 -16.63% | 3,550 | ₹58 13.17% | 28,250-9.6% |
| 1,18,000-1.87% | ₹27.1 -13.41% | 3,600 | ₹82.6 0.79% | 42,750-0.58% |
| 1,19,7500% | ₹14.2 -23.86% | 3,650 | ₹124 0.56% | 12,000-2.04% |
| 1,47,000-1.34% | ₹9.9 -18.51% | 3,700 | ₹161.1 -2.48% | 3,5000% |
| 36,5005.79% | ₹6.35 -16.44% | 3,750 | ₹194.25 -0.84% | 2,0000% |
| 70,5001.07% | ₹4.3 -20.37% | 3,800 | ₹252 0% | 1,0000% |
| 39,7500% | ₹2.95 -21.33% | 3,850 | ₹299.4 0% | 5000% |
| 41,000-8.37% | ₹2.4 -15.78% | 3,900 | - | - |
| 41,750-16.08% | ₹1.6 -11.11% | 4,000 | ₹345 0% | 2500% |
| 2500% | ₹18 0% | 4,100 | - | - |
| 1,2500% | ₹0.25 -95.83% | 4,200 | - | - |
Torrent Urja, is a wholly owned subsidiary of Torrent Green Energy Pvt. Ltd. The company is incorporated to develop a solar-plus-wind power project.
The transaction involves around 38.75 lakh shares, priced at ₹1,600 each, being offloaded by JB Chemicals employees who recently converted their stock options.
The acquisition values JB Chemicals at ₹25,689 crore on a fully diluted basis, according to the company’s official announcement.
On the operating front, EBITDA for the quarter was reported at ₹964 Crore. It was 9.20% higher than ₹883 in Q4FY24.
Here are some of the stocks that may see significant price movement today: JK Cement, KEC International, Macrotech Developers, etc.
Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.
The USFDA examined Torrent's manufacturing plant in Pithampur during the September quarter and issued a Form 483 with one observation.
The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.
When compared to the previous quarter, revenue growth was modest at 1.05%, while net profits experienced a slight decline of 0.88%.
In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
